SCHEMBL926067

SCHEMBL926067

CSSCC(C)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5200403 0.79
SCHEMBL16899660 0.74
SCHEMBL23892794 0.70
SCHEMBL16899631 0.70
SCHEMBL537197 0.67
SCHEMBL13974336 0.67 DNM1 (0.33)
SCHEMBL16899663 0.65
Hydrochloric Acid SCHEMBL4863550 0.64
Hydrochloric Acid SCHEMBL9339671 0.64
SCHEMBL31287505 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044122-B1 ANTAGONIST ANTIBODY AGAINST EPHA2 FOR THE TREATMENT OF CANCER SANOFI SA (FR) 2018-03-28 EP claimed
US-20110002947-A1 LEPTOMYCIN DERIVATIVES SANOFI-AVENTIS (FR) 2011-01-06 US claimed
US-7816543-B2 Leptomycin derivatives SANOFI-AVENTIS (FR) 2010-10-19 US claimed
US-20090182038-A1 Leptomycin Derivatives SANOFI-AVENTIS (FR) 2009-07-16 US claimed
US-20170343550-A1 NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER SANOFI SA (FR) 2017-11-30 US disclosed
US-8952147-B2 Conjugates, preparation thereof, and therapeutic use thereof SANOFI (FR) 2015-02-10 US disclosed
EP-2174644-B1 Cosmetic composition comprising a dibenzoylmethane derivative and a dithiolane; Photostabilization of a dibenzoylmethane derivative OREAL (FR) 2012-11-14 EP disclosed
US-20120225089-A1 NOVEL CONJUGATES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF SANOFI (FR) 2012-09-06 US disclosed
US-20110002947-A1 LEPTOMYCIN DERIVATIVES SANOFI-AVENTIS (FR) 2011-01-06 US disclosed
US-7816543-B2 Leptomycin derivatives SANOFI-AVENTIS (FR) 2010-10-19 US disclosed
US-20090182038-A1 Leptomycin Derivatives SANOFI-AVENTIS (FR) 2009-07-16 US disclosed